Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial
BackgroundThe appropriate age range for breast cancer screening remains a matter of debate. We aimed to estimate the effect of mammographic screening at ages 40–48 years on breast cancer mortality.MethodsWe did a randomised, controlled trial involving 23 breast screening units across Great Britain....
Guardado en:
Autores principales: | Stephen W. Duffy, Daniel Vulkan, Howard Cuckle, Dharmishta Parmar, Shama Sheikh, Robert A. Smith, Andrew Evans, Oleg Blyuss, Louise Johns, Ian O. Ellis, Jonathan P. Myles, Peter Sasieni, Sue Moss |
---|---|
Formato: | Artigo |
Lenguaje: | inglés |
Publicado: |
2020
|
Acceso en línea: | https://doi.org/10.1016/s1470-2045(20)30398-3 http://www.thelancet.com/article/S1470204520303983/pdf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial
por: Duffy, Stephen W, et al.
Publicado: (2020) -
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
por: Duffy, Stephen, et al.
Publicado: (2020) -
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT
por: Stephen W. Duffy, et al.
Publicado: (2020) -
False-positive results in the randomised controlled trial of mammographic screening from age 40 (‘Age’ trial)
por: Johns, Louise E, et al.
Publicado: (2010) -
Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial
por: Sue Moss, et al.
Publicado: (2015)